Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FAVQC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,940
Award facts
- Contract value 100% obligated
- $11,940.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. for GARDASIL 9 Syringe 0.5ML with a ceiling value of $11,940.13. This firm fixed-price delivery order was issued on June 23, 2025, with an ultimate completion date of June 24, 2025, and is associated with the company's larger SPE2DB Indefinite Delivery Contract valued at $499,999,999 through November 2026. The delivery order carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. GARDASIL 9 is a vaccine used for the prevention of human papillomavirus infections, supporting the Department of Defense's medical supply requirements for military healthcare facilities worldwide.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor on this award. The company has maintained a substantial federal contract portfolio focused on delivering comprehensive pharmaceutical products to military and federal healthcare systems since its SAM.gov registration in 2001. This delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, leveraging its single-award IDC with the Defense Logistics Agency to provide branded and generic medications, biologics, and medical consumables to Department of Defense facilities.
Quick answers
Who was awarded contract SPE2DB25FAVQC?
SPE2DB25FAVQC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 23, 2025.
How much is contract SPE2DB25FAVQC worth?
The government has obligated $11,940 on SPE2DB25FAVQC.
Is contract SPE2DB25FAVQC an order under another contract?
Yes. SPE2DB25FAVQC is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVQC competed?
The extent of competition for SPE2DB25FAVQC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award